Pancreatic Cancer Treatment
Treatment for pancreatic cancer depends on the cancer stage (spread). Treatment usually includes some combination of chemotherapy and surgery. Other treatment includes medications to control nausea, a cancer diet, and narcotic pain medications or nonsteroidal anti-inflammatory medications to control pain.
Treatment options for pancreatic cancer include:
- Surgery for pancreatic cancer:
- Often used to relieve jaundice
- Chemotherapy for pancreatic cancer:
- Gemcitabine (Gemzar)
- Fluorouracil (Adrucil, Efudex, Fluoroplex)
- Erlotinib (Tarceva)
- Capecitabine (Xeloda)
- Nonsteroidal anti-inflammatory medications for pain:
- Ibuprofen (Motrin, Advil, Nuprin, NeoProfen)
- Ketoprofen (Actron, Orudis, Oruvail)
- Naproxen (Anaprox, Naprosyn, Aleve)
- Narcotic pain medication:
- For moderate to severe pain
- For short term use only
- Medications for nausea:
Pancreatic Cancer Questions For Doctor
The following are some important questions to ask before and after the treatment of pancreatic cancer.
Questions to ask before treatment:
- What are my treatment options?
- Is surgery an option for me?
- What are the risks associated with treatment?
- Do I need to stay in the hospital?
- How long will I be in the hospital?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- When can I resume my normal activities?
- When can I return to work?
- What else can I do to reduce my risk of pancreatic cancer complications?
- Are my children at risk for this condition?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Pancreatic Cancer Specialist
Continue to Pancreatic Cancer Home Care
- Burris HA 3rd. Recent updates on the role of chemotherapy in pancreatic cancer. Semin Oncol. 2005 Aug;32(4 Suppl 6):S1-3. 
- Farrow B, Sugiyama Y, Chen A, Uffort E, Nealon W, Mark Evers B. Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg. 2004 Jun;239(6):763-9. 
- Holly EA, Chaliha I, Bracci PM, Gautam M. Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area. Clin Gastroenterol Hepatol. 2004 Jun;2(6):510-7. 
- Lockhart AC, Rothenberg ML, Berlin JD. Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology. 2005 May;128(6):1642-54. 
- Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst. 2005 Oct 5;97(19):1458-65. 
- Verma M. Pancreatic cancer epidemiology. Technol Cancer Res Treat. 2005 Jun;4(3):295-301.